According to Eurekalert on September 4, an important new review study conducted by a team of scientists, including public health researchers at the University of Massachusetts Amherst, identified the three most effective strategies for quitting smoking.
1. Varenicline, a prescription drug with brand names such as Chantix and Champix;
2. Cytisine, a plant-based compound that is not widely available in the United States, but is sold as a natural health product (Cravv®) in Canada and Central and Eastern Europe, and requires a prescription in the UK;
3. Nicotine vapes.
The review, sponsored by the nonprofit Cochrane Tobacco Addiction Group (CTAG) and published in the journal Addiction, was led by CTAG senior authors Jamie Hartmann-Boyce, assistant professor of health policy and management at the School of Public Health and Health Sciences at the University of Massachusetts Amherst, and Jonathan Livingstone-Banks, a researcher at the University of Oxford.
The review notes that the three best strategies work best when combined with behavioral supports, such as counseling. Bupropion and nicotine replacement therapy (NRT) are also effective, especially when NRT patches are combined with faster-acting forms such as gum.
CTAG’s new summary outlines the key findings of 14 Cochrane reviews published between 2021 and 2023. Three key reviews include:
Updated NRT review: found that combining fast-acting forms of NRT (such as gum, lozenges, sprays) with NRT patches can help more people quit smoking than single forms of NRT;
vape review: As a dynamic system review, the latest update concludes that nicotine-containing vapes can improve quit rates more than NRT, and there is also moderate certainty evidence that quit rates are improved compared to nicotine-free vapes;
2023 Drug and vape intervention review: covers all drugs and vapes approved for smoking cessation worldwide. The results show that nicotine vapes, varenicline and cytisine all have high-certainty evidence, followed by combined NRT. An updated review of nicotine receptor partial agonists showed that in studies directly comparing cytisine and varenicline, there may be no difference in the effects of the two on smoking cessation. The review includes 75 trials.
A research team at the University of Massachusetts recently conducted an important review study and found that nicotine vapes are one of the three most effective strategies for quitting smoking. The study was conducted by a team of scientists including a public health researcher at the University of Massachusetts Amherst, and the conclusions were published in the journal Addiction.
The review pointed out that nicotine vapes are best used in combination with behavioral support as a smoking cessation tool. The results of this study showed that nicotine vapes have shown significant effects in helping people quit smoking, especially when combined with behavioral support.
In this study, nicotine vapes were listed as one of the three best smoking cessation strategies, and were considered to have high-certainty evidence along with other drugs and therapies. This finding provides scientific support for the use of nicotine vapes as a smoking cessation tool, and also highlights the importance of this method in the field of smoking cessation.
As an vape brand committed to health and safety, Veehoo vapes will continue to pay attention to the latest research results and scientific discoveries to continuously improve products, provide vape products that meet regulatory standards, and provide users with a better smoking cessation experience and healthy choices. Through research collaboration and continuous innovation with a team of scientists, Veehoo is committed to helping more people achieve their smoking cessation goals and promoting public health and well-being.
Tags: UMass vape study，The most effective smoking cessation strategy，veehoo vape